Cyberounds Logo
September 29, 2020 | LOGIN | REGISTER | HELP | 

email a friend print Bookmark and Share
New Frontiers in the Treatment and Management of Smoking Cessation
CME credit is no longer available for this conference.
Eric Siu, M.Sc., Nael Al Koudsi, H.B.Sc., Man Ki Ho, H.B.Sc., Rachel F. Tyndale, M.Sc., Ph.D.

Dr. Tyndale is a Scientist at the Centre for Addiction and Mental Health and a Professor of Pharmacology, University of Toronto. Mr. Siu, Mr. Al Koudsi, and Miss Ho are doctoral students in the Department of Pharmacology at the University of Toronto.

Within the past 12 months, Dr. Tyndale has been the Chief Scientific Officer and a shareholder of Nicogen Inc. Mr. Siu, Mr. Al Koudsi and Miss Ho report no commercial conflicts of interest.

This activity is made possible by an unrestricted educational grant from Pfizer. Pfizer

Release Date: 08/22/2006
Termination Date: 08/22/2009

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the epidemiology of smoking among U.S. population
  • Discuss the neurophysiological basis of nicotine addiction, including the role of the reward pathway
  • Discuss the genetic contribution to smoking behaviours and how genetic variation in neurotransmitter pathways might contribute
  • Discuss pharmacotherapeutic treatment strategies that promote smoking cessation.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity